Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
This study has been completed.
Study NCT00210691   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on September 13, 2005.   Last Updated on November 18, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial